LAUSR

Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment

Sign Up to like & get
recommendations!
1 Published in 2022 at "Antimicrobial Agents and Chemotherapy"

DOI: 10.1128/aac.00114-22

Abstract: The rate at which parasitemia declines in a host after treatment with an antimalarial drug is a major metric for assessment of antimalarial drug activity in preclinical models and in early clinical trials. However, this… read more here.

Keywords: antimalarial drug; drug activity; parasite viability; activity ... See more keywords